s-488410
Vaccineexperimental
Clinical trial activity
1 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2012 (NCT01592617)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- s-488410
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01592617 | Phase 2 | May 1, 2012 | Fukushima Medical University, Shiga University, Shionogi, Showa University, Tohoku University, University of Chicago, University of Tokyo |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fukushima Medical University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Shiga University | Academic/Hospital | 1 | 1 | 1 | 2012 |
| Shionogi | For profit | 1 | 0 | 1 | 2012 |
| Showa University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Tohoku University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| University of Chicago | Academic/Hospital | 1 | 0 | 1 | 2012 |
| University of Tokyo | Academic/Hospital | 1 | 0 | 1 | 2012 |
7 organizations
Page 1 / 1